Clinical Trial: QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07620041) titled 'QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction' on May 12.

Brief Summary: A clinical trial of QLC5508 for advanced solid tumors

The goal of this clinical trial is to learn if QLC5508 can be given safely to adults with advanced solid tumors. It will also learn how two different formulations of QLC5508 compare in the body, and whether other drugs affect QLC5508. The main questions it aims to answer are:

Does a single injection of QLC5508 change the heart's electrical activity (QTc interval)?

How do the test formulation and the reference formulation of QLC5508 compare in the body...